Keisuke Shigeta

10PUBLICATIONS
39CO-AUTHORS
Molecular targetsPredictive and prognostic markersBiological physicsCell physiologyCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 14, 2025
Targeting KRAS Inhibitor-Resistant Pancreatic Cancer with an MUC1-C Antibody-Drug Conjugate.

Hiroki Ozawa, Kazuki Takahashi, Tomoki Motegi

|Apr 15, 2024
Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas.

Ayako Nakashoji, Naoki Haratake, Atrayee Bhattacharya

|Jul 07, 2023
Long-Term Prognosis and Treatment Strategy of Persistent PSA After Radical Prostatectomy.

Takahiro Komori, Kazuhiro Matsumoto, Takeo Kosaka

|Jul 05, 2023
ASO Author Reflections: Discussing the Optimal Treatment Strategy Against Persistent PSA After Radical Prostatectomy.

Kazuhiro Matsumoto, Takahiro Komori, Mototsugu Oya

|Jul 03, 2023
Editorial Comments to "Preoperative risk classification for intravesical recurrence after laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma in a multi-institutional cohort".

Keisuke Shigeta

|Jan 13, 2023
IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer.

Keisuke Shigeta, Masanori Hasegawa, Takako Hishiki

Pageof 2

Frequent Collaborators

3 joint publications

Takeo Kosaka

3 joint publications

Mototsugu Oya

2 joint publications

Takeo Kosaka

2 joint publications

Shuji Mikami